Where does Circuit Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Circuit Therapeutics, Inc. ranks #20,929 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Circuit Therapeutics, Inc. hold?

Circuit Therapeutics, Inc. holds 13 US utility patents granted between 2017 and 2021, spanning 8 technology areas.

What is Circuit Therapeutics, Inc.'s Innovation Score?

Circuit Therapeutics, Inc. has an Innovation Score of 34.1 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Circuit Therapeutics, Inc. focus on?

Circuit Therapeutics, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 12 patents, ranking #1,593 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Circuit Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Circuit Therapeutics, Inc.'s recent grant velocity is -92% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Circuit Therapeutics, Inc.'s patents?

Circuit Therapeutics, Inc.'s patents average 35.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Circuit Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Circuit Therapeutics, Inc.

USPTO PatentsView assignee record - 13 granted patents across 8 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Circuit ranks #20,929 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 8 technology areas.

#20,929
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.1/100): 35.2
avg claims per patent: -92%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20929 · US Corporation #20,929 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,929/49,997
PHOTO-FINISH Chongqing University…
CPC-NARROW A61P · 8 areas
INNOV-THIN 34.1/100
CLAIMS-DENSE 35.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -92% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chongqing University of Arts and Sciences (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Circuit’s 34.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (27%) Velocity 0.0 pts (0%) Breadth 10.0 pts (29%) Claim depth 15.0 pts (44%)

Qualcomm Incorporated · highest

85
Circuit Therapeutics · this assignee

34
3D Lighting… · lowest

7

What this shows Circuit's Innovation Score is 34.1/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Circuit?

Each dot is one of Circuit’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Circuit’s own 35.2 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Circuit vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Circuit's grants concentrate

Circuit Therapeutics, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 92.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (5 grants) versus a trough of 1 in 2021. By volume, Circuit sits between Chongqing University of Arts and Sciences and Cleveland Reclaim Industries.

Chongqing Univers…

13
Chris Cam Industry

13
Chromalox

13
Circuit Seed

13
Cixi City Liyuan…

13
Clarity Medical S…

13
Cleland Sales

13
Cleveland Reclaim…

13
Circuit Therapeut… ◀

13

What this shows Circuit holds 13 patents at rank #20,951, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Circuit

By rank, the assignees closest to #20,951 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Circuit's primary technology class.

Circuit's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Circuit Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	5	38.5%
2018	3	23.1%
2019	4	30.8%
2021	1	7.7%

Which technologies does Circuit Therapeutics, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 12

A61B - DIAGNOSIS; SURGERY; Identification 10

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

G02B - Optical Elements, Systems OR Apparatus 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Circuit Therapeutics, Inc.'s patent record in context - here's where to go next.

Circuit Therapeutics, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 92.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #20,929 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Circuit Therapeutics, Inc. against Chongqing University of Arts and Sciences, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.